via Iwamotoscott Architecture
November 22, 2019 09:42 AM ESTUpdated November 27, 12:45 PM
R&D

Alexan­dria is think­ing big as it lays out plans for 1.6M square foot Bay Area biotech cam­pus

John Carroll

Editor & Founder

The lat­est sprawl­ing biotech cam­pus un­der de­vel­op­ment in the Bay Area is tak­ing shape.

San Fran­cis­co Busi­ness Times re­porter Ron Leu­ty has the sto­ry …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

Met­sera rais­es $215M for stud­ies of GLP-1 and amylin obe­si­ty drugs

Adap­ti­m­mune's sec­ond T cell re­cep­tor cell ther­a­py for rare sar­co­mas pass­es piv­otal test

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

J&J takes 340B fight with fed­er­al gov­ern­ment to court

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times